# Aperiam Bio, Inc. — Form D

Aperiam Bio, Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-07. $3.7M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-03-07
- Form: D
- Accession: 0001911739-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $3.7M
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2022-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-436201

## Issuer

- Name: Aperiam Bio, Inc.
- CIK: 0001911739
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 2205 NORTH LAMAR BLVD. UNIT 511, AUSTIN, TX, 78705
- Phone: 512-318-5584

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Austin Cole | Director | Austin, TX |
| Austin Cole | Executive Officer | Austin, TX |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-09-27](https://search.stillhousedata.com/formd/0001956434-23-000003) | D | — | $4.0M |

## More

- [CIK 1911739 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1911739&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001911739-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.